| A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease. (NCT00422513) | Hoffmann-La Roche | 2007-03-01 |
| Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery (NCT00651573) | The Cleveland Clinic | 2007-03-01 |
| A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. (NCT00413894) | Hoffmann-La Roche | 2007-03-01 |
| Treatment of Anemia in the 2nd Year of Life. Comparison of the Efficacy of Two Different Iron Preparations. (NCT00248716) | Soroka University Medical Center | 2007-02-01 |
| A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients. (NCT00442416) | Hoffmann-La Roche | 2007-02-01 |
| Periconceptional Iron Supplementation in Rural Bangladesh (NCT00953134) | The Hospital for Sick Children | 2007-02-01 |
| Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia (NCT00588146) | Mayo Clinic | 2007-01-01 |
| An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial (NCT00534456) | Amgen | 2007-01-01 |
| A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies (NCT00776425) | Hoffmann-La Roche | 2007-01-01 |
| Evaluation of Reproducibility of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers (NCT00367380) | Malaria Vaccine and Drug Development Center | 2006-12-01 |
| Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis (NCT00434330) | Affymax | 2006-12-01 |
| A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients (NCT00394953) | Hoffmann-La Roche | 2006-12-01 |
| Darbepoetin Alfa With or Without Intravenous (IV) Iron (NCT00401544) | Amgen | 2006-12-01 |
| Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure (NCT00399269) | Cadila Pharnmaceuticals | 2006-12-01 |
| The Use of Ultra Rice Compared to Iron Drops Consumed by Anemic Children (NCT00839761) | Federal University of Minas Gerais | 2006-12-01 |
| A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy (NCT00386152) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-11-01 |
| Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study (NCT00396123) | University of Michigan | 2006-11-01 |
| Dynepo Infrequent Dosing Study (NCT00450333) | Shire | 2006-10-30 |
| Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer (NCT00381836) | University of Aarhus | 2006-10-01 |
| The Israeli Trigger for Blood Transfusions in the ICU (NCT00413816) | Rabin Medical Center | 2006-10-01 |
| An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease (NCT00440557) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-09-01 |
| Timing of Cord Clamping and Neonatal Hemoglobin (NCT00371228) | Oklahoma State University Center for Health Sciences | 2006-09-01 |
| LEARN-6™: A Prospective, Observational Nursing Home Study (NCT00727571) | Amgen | 2006-09-01 |
| A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B (NCT02608060) | Hoffmann-La Roche | 2006-09-01 |
| A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD) (NCT00431496) | Amgen | 2006-09-01 |
| Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients (NCT00382044) | Sir Charles Gairdner Hospital | 2006-09-01 |
| STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients (NCT00364845) | Amgen | 2006-09-01 |
| Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (NCT00372489) | Affymax | 2006-09-01 |
| COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia. (NCT00377481) | Hoffmann-La Roche | 2006-09-01 |
| Effect of Iron Versus Multiple Micronutrient Supplementation on Anemia in Preschool Children of Malaria-Endemic Area (NCT00628459) | Centre National de la Recherche Scientifique et Technologique | 2006-08-01 |
| Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study (NCT00386126) | Hospital de Clinicas de Porto Alegre | 2006-08-01 |
| A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities. (NCT00337935) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-07-01 |
| Evaluation Of A New Vitamin E-Bonded Membrane On Anemia And Oxidative Stress In End-Stage Renal Disease Patients (NCT00687258) | A. Manzoni Hospital | 2006-07-01 |
| Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients (NCT00338234) | Assistance Publique - Hôpitaux de Paris | 2006-06-01 |
| Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants (NCT00285662) | Papua New Guinea Institute of Medical Research | 2006-06-01 |
| A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women (NCT00360425) | AMAG Pharmaceuticals, Inc. | 2006-05-01 |
| A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. (NCT00327535) | Hoffmann-La Roche | 2006-05-01 |
| Thai Cancer Anemia Survey in Chulalongkorn Hospital (NCT01018043) | Janssen-Cilag Ltd.,Thailand | 2006-04-01 |
| A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy (NCT02624141) | Hoffmann-La Roche | 2006-04-01 |
| Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury (NCT00313716) | Claudia Sue Robertson | 2006-04-01 |
| Iron Supplementation to Reduce Preschoolers Anemia: Comparison Between Intermittent and Cyclic Procedure (NCT00992823) | Sao Jose do Rio Preto Medical School | 2006-03-01 |
| A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy (NCT00306267) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-03-01 |
| A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients (NCT00344409) | Kyowa Kirin Co., Ltd. | 2006-03-01 |
| Effectiveness of Laying-on-of-hands for Sickle Cell Disease (NCT01518218) | MOA Health Science Foundation | 2006-03-01 |
| Prostate Adenocarcinoma TransCutaneous Hormones (NCT00303784) | University College, London | 2006-03-01 |
| Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer (NCT00294203) | University of Florida | 2006-02-01 |
| Etiology of Anemia (NCT00302939) | National Institute on Aging (NIA) | 2006-01-01 |
| Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients (NCT00721188) | American Regent, Inc. | 2006-01-01 |
| Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer (NCT00661999) | Mayo Clinic | 2006-01-01 |
| A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease (NCT00641589) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-01-01 |
| A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia (NCT01394991) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-01-01 |
| A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies (NCT00210977) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-12-01 |
| Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors (NCT00559195) | Centre Hospital Regional Universitaire de Limoges | 2005-11-01 |
| Safety Study of ECO Conversion System For Red Blood Cells. (NCT00261274) | Velico Medical | 2005-11-01 |
| Prevalence and Treatment of Anemia in Rehabilitation Patients (NCT00511901) | University of Medicine and Dentistry of New Jersey | 2005-11-01 |
| Appropriate Complmentary Feeding Strategies in Infants (NCT01412411) | Aga Khan University | 2005-10-01 |
| A Study of Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on Dialysis (NCT02827266) | Hoffmann-La Roche | 2005-10-01 |
| Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2) (NCT00398749) | Janssen-Cilag B.V. | 2005-10-01 |
| A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients (NCT00246298) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-10-01 |
| The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients (NCT00247507) | Far Eastern Memorial Hospital | 2005-09-01 |
| A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. (NCT00212875) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-09-01 |
| Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients (NCT00228436) | Affymax | 2005-09-01 |
| Controlling Anemia During Pregnancy: Sprinkles Versus IFA Tablets (NCT06516081) | The Hospital for Sick Children | 2005-09-01 |
| Intravenous Iron Versus Oral Iron for Severe Postpartum Anemia (NCT00660933) | Hospital Clinic of Barcelona | 2005-09-01 |
| Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer (NCT00255749) | Jonsson Comprehensive Cancer Center | 2005-08-01 |
| Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies (NCT00239239) | Amgen | 2005-08-01 |
| Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa (NCT00210626) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-08-01 |
| Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy (NCT00144131) | Amgen | 2005-08-01 |
| Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia (NCT00740246) | American Regent, Inc. | 2005-07-01 |
| Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia (NCT00563446) | Hospital Authority, Hong Kong | 2005-07-01 |
| Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan (NCT00120237) | Gynuity Health Projects | 2005-07-01 |
| Safety and Efficacy of Iron Sucrose in Children (NCT00239642) | American Regent, Inc. | 2005-07-01 |
| Evaluation of Home-Based Management of Fever in Urban Ugandan Children (NCT00115921) | London School of Hygiene and Tropical Medicine | 2005-07-01 |
| Peginesatide for Anemia in Chronic Hemodialysis Patients (NCT00228449) | Affymax | 2005-07-01 |
| Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients (NCT00204334) | University Hospital Muenster | 2005-06-01 |
| Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease (NCT00317226) | American Regent, Inc. | 2005-06-01 |
| Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia (NCT00264108) | Janssen-Cilag B.V. | 2005-06-01 |
| Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding (NCT00395993) | American Regent, Inc. | 2005-05-01 |
| Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy (NCT00210600) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-05-01 |
| VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease (NCT00317239) | American Regent, Inc. | 2005-05-01 |
| Treatment of Anemia in Diabetic Subjects With CKD (NCT00240734) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-03-01 |
| Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease (NCT00121602) | Amgen | 2005-03-01 |
| PROCRIT and Short-Term Outcomes in Orthopedic Surgery (NCT00236405) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-03-01 |
| Adherence With Iron Sprinkles Among High-Risk Infants (NCT00136266) | Centers for Disease Control and Prevention | 2005-03-01 |
| The Community Effectiveness of IPTi in Southern Tanzania (NCT00152204) | Swiss Tropical & Public Health Institute | 2005-03-01 |
| Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease (NCT00109291) | Affymax | 2005-03-01 |
| An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation (NCT00210587) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-02-01 |
| Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia (NCT00396292) | American Regent, Inc. | 2005-02-01 |
| A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies (NCT02564094) | Hoffmann-La Roche | 2005-02-01 |
| A Crossover Safety Study of Ferumoxytol Versus Placebo (NCT00255450) | AMAG Pharmaceuticals, Inc. | 2005-01-01 |
| Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients (NCT00711958) | Sandoz | 2004-11-01 |
| A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal Anemia (NCT02569515) | Hoffmann-La Roche | 2004-10-01 |
| Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer (NCT00095277) | Amgen | 2004-10-01 |
| A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia (NCT00090753) | Hoffmann-La Roche | 2004-10-01 |
| Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis (NCT00173706) | National Taiwan University Hospital | 2004-10-01 |
| Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer (NCT00060398) | Eastern Cooperative Oncology Group | 2004-09-29 |
| A Study to Observe the Causes and Treatment of Anemia in Critically Ill Children (NCT00211055) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-09-01 |
| Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia (NCT00281892) | German CLL Study Group | 2004-09-01 |
| Using Iron Supplementation to Decrease Iron Deficiency Anemia in Infants and Young Children in India (NCT00213161) | The Hospital for Sick Children | 2004-08-01 |
| A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study (NCT00115167) | Amgen | 2004-08-01 |